Source: MarketScreener

Verastem: Verastem : Oncology to Present at the Jefferies Virtual Healthcare Conference

(marketscreener.com) Verastem, Inc. , a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced that the Company will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020 at 2:30 p.m. EDT. A live webcast of the presentation will be available on the investors...https://www.marketscreener.com/VERASTEM-INC-9895017/news/Verastem-Oncology-to-Present-at-the-Jefferies-Virtual-Healthcare-Conference-30685924/?utm_medium=RSS&utm_content=20200528

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Brian Stuglik's photo - CEO of Verastem

CEO

Brian Stuglik

CEO Approval Rating

66/100

Verastem is a biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of cancer. Read more